Candidiasis, Oral

"Candidiasis, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)

Descriptor ID	D002180
MeSH Number(s)	C01.703.160.180 C07.465.130
Concept/Terms	Candidiasis, Oral Candidiasis, Oral Candidiases, Oral Oral Candidiases Oral Candidiasis Thrush Moniliasis, Oral Moniliases, Oral Oral Moniliases Oral Moniliasis

Below are MeSH descriptors whose meaning is more general than "Candidiasis, Oral".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Mycoses [C01.703]
Candidiasis [C01.703.160]
Candidiasis, Oral [C01.703.160.180]
Stomatognathic Diseases [C07]
Mouth Diseases [C07.465]
Candidiasis, Oral [C07.465.130]

Below are MeSH descriptors whose meaning is more specific than "Candidiasis, Oral".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Candidiasis, Oral" by people in this website by year, and whether "Candidiasis, Oral" was a major or minor topic of these publications.

Bar chart showing 19 publications over 10 distinct years, with a maximum of 5 publications in 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	3	0	3
1999	3	0	3
2000	0	1	1
2001	1	1	2
2002	4	1	5
2003	1	0	1
2004	0	1	1
2005	1	0	1
2011	1	0	1
2015	1	0	1

Below are the most recent publications written about "Candidiasis, Oral" by people in Profiles.

Kapitan M, Niemiec MJ, Millet N, Brandt P, Chowdhury MEK, Czapka A, Abdissa K, Hoffmann F, Lange A, Veleba M, Nietzsche S, Mosig AS, L?ffler B, Marquet M, Makarewicz O, Kline KA, Vylkova S, Swidergall M, Jacobsen ID. Synergistic interactions between Candida albicans and Enterococcus faecalis promote toxin-dependent host cell damage. Proc Natl Acad Sci U S A. 2025 Nov 18; 122(46):e2505310122.

View in: PubMed
Vila TV, Chaturvedi AK, Rozental S, Lopez-Ribot JL. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. Antimicrob Agents Chemother. 2015 Dec; 59(12):7611-20.

View in: PubMed
Yadev NP, Murdoch C, Saville SP, Thornhill MH. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis. Microb Pathog. 2011 Jun; 50(6):278-85.

View in: PubMed
S?nchez-Vargas LO, Ortiz-L?pez NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gait?n-Cepeda LA, Quind?s G. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Rev Iberoam Micol. 2005 Jun; 22(2):83-92.

View in: PubMed
Tirado G, Jove G, Kumar R, Noel RJ, Reyes E, Sepulveda G, Yamamura Y, Kumar A. Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female. AIDS Res Hum Retroviruses. 2004 Jun; 20(6):684-6.

View in: PubMed
Li X, Brown N, Chau AS, L?pez-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother. 2004 Jan; 53(1):74-80.

View in: PubMed
Leigh JE, Steele C, Wormley F, Fidel PL. Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol Immunol. 2002 Oct; 17(5):311-4.

View in: PubMed
Martinez M, L?pez-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol. 2002 Sep; 40(9):3135-9.

View in: PubMed
Perea S, L?pez-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother. 2002 Jun; 46(6):1695-703.

View in: PubMed
Bachmann SP, Patterson TF, L?pez-Ribot JL. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol. 2002 Jun; 40(6):2228-30.

View in: PubMed

People

Explore

Similar Concepts

Top Journals